seed
Stage
1
Investors
About
Capable is developing AI-enabled, peptide and nucleotide therapeutic drugs aimed at improving human health by targeting rare and under-treated sleep disorders and enhancing human cognitive performance under sleep deprivation.
Explore Capable's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.